Smofkabiven Peripheral 230 mg

SMOFKABIVEN Peripheral 230 mg is an intravenous emulsion containing leucine, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is suitable for peripheral administration.

SMOFKABIVEN Peripheral 230 mg is primarily used for nutritional support in patients who cannot consume food orally. This emulsion provides essential amino acids, including leucine, which are crucial for muscle protein synthesis and overall health. It is often used in clinical settings to ensure adequate nutrition for patients who require intravenous feeding.

When administered intravenously, SMOFKABIVEN Peripheral 230 mg provides essential nutrients directly into the bloodstream. This can help maintain or improve nutritional status in patients who are unable to eat or absorb nutrients through the digestive system. The emulsion is designed to be well-tolerated, but individual responses may vary.

SMOFKABIVEN Peripheral 230 mg should be administered under medical supervision. It is important to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

SMOFKABIVEN Peripheral 230 mg may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this product.